iProcess Global Research is a leading provider of Biospecimens and Research Globally. We have a global network of over 5000+ sites and the ability to customize any collection as per clients needs. As iProcess completes 20 years in 2024, it has successfully undertaken major projects globally in Oncology, Cardiology, Infectious Diseases etc. Our clients include most of the Top 100 Pharmaceutical and Lifescience Companies, the leading diagnostic companies involved in cutting edge research, to companies revolutionizing personalized medicine as well as Govt research organizations like the NIH. For Banked or Prospective Collections, iProcess is able to deliver the highest quality specimens from Tissues to Blood, Plasma, Serum, Urine, Stool , Saliva, Swabs and any other Biofluids as needed by our clients. We are also engaged by our clients to access to samples for approvals with FDA, including Covid, STI , Liquid Biopsy etc.
In 2022, iProcess launched its Lab Services division. We provide extensive R&D testing services to our clients.